These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8190659

  • 1. [Evaluation of the efficiency of gemfibrozil in treating hyperlipidemia type IIb and IV].
    Polakowska M, Broda G, Rywik S, Piotrowski W, Bednarska M, Kuźmińska A, Pytlak A, Chotkowska E.
    Pol Arch Med Wewn; 1994 Jan; 91(1):9-18. PubMed ID: 8190659
    [Abstract] [Full Text] [Related]

  • 2. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
    Bednarska-Makaruk M, Kuźmińska A, Chotkowska E, Kurjata P, Polakowska M, Broda G, Rywik S.
    Pol Arch Med Wewn; 1992 Mar; 87(3):149-56. PubMed ID: 1523145
    [Abstract] [Full Text] [Related]

  • 3. [Gemfibrozil in the treatment of hyperlipoproteinemias].
    Monova D, Petrova V, Belovezhdov N.
    Vutr Boles; 1991 Mar; 30(2):56-8. PubMed ID: 1891900
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activity profile of gemfibrozil on the major plasma lipoprotein parameters.
    Sirtori CR, Franceschini G, Gianfranceschi G, Vaccarino V, Chiesa G, Maderna P, Bertoli M, Calabresi L.
    Eur J Epidemiol; 1992 May; 8 Suppl 1():120-4. PubMed ID: 1505648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T, Nakai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Takeda R.
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
    Sznajd J, Malczewska-Malec M, Idzior-Waluś B, Iwanejko J, Nowacki G.
    Przegl Lek; 1987 Feb; 44(12):837-43. PubMed ID: 3330253
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of gemfibrozil on serum lipid levels.
    Dahlén G, Gillnäs T, Børresen AL, Berg K, Ericson C.
    Artery; 1980 Feb; 7(3):224-31. PubMed ID: 7008748
    [Abstract] [Full Text] [Related]

  • 11. [Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia].
    Julius U, Hora C, Gross P, Fücker K, Bergmann S, Hanefeld M.
    Fortschr Med; 1992 Dec 20; 110(35-36):669-72. PubMed ID: 1487226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J, Martorell J.
    Clin Ther; 1980 Dec 20; 3(4):234-41. PubMed ID: 7273061
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)].
    Sznajd J, Malczewska-Malec M, Idzior-Waluś B, Jamska B, Nowacki G.
    Przegl Lek; 1987 Dec 20; 44(12):828-36. PubMed ID: 3330252
    [No Abstract] [Full Text] [Related]

  • 15. Fenofibrate therapy of hypertriglyceridaemia. Differential effects on LDL cholesterol level in type IV and in type IIb primary hyperlipoproteinaemia.
    Sommariva D, Bonfiglioli D, Pogliaghi I, Ottomano C, Fasoli A.
    Eur J Clin Pharmacol; 1984 Dec 20; 26(6):741-4. PubMed ID: 6489413
    [Abstract] [Full Text] [Related]

  • 16. Changes induced by gemfibrozil on lipidic, coagulative and fibrinolytic pattern in patients with type IV hyperlipoproteinemia.
    Avellone G, Di Garbo V, Panno AV, Cordova R, Lepore R, Strano A.
    Int Angiol; 1988 Dec 20; 7(3):270-7. PubMed ID: 3198979
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Multicenter study of the efficacy and tolerance of gemfibrozil and fenofibrate in the treatment of primary hyperlipoproteinemia].
    Manojlović D, Lepsanović L, Micić D, Sumarac M, Kendereski L, Popović V, Mićić J.
    Srp Arh Celok Lek; 1991 Dec 20; 119(1-2):22-5. PubMed ID: 1788614
    [Abstract] [Full Text] [Related]

  • 19. CI-924 effects on plasma lipids in patients with type II and type IV hyperlipoproteinaemia.
    Corder CN, Kloer HU, Price MD.
    Eur J Clin Pharmacol; 1989 Dec 20; 37(5):477-81. PubMed ID: 2598985
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.